In this system, DOX enhances the immunogenicity of GBM by inducing immunogenic cell death (ICD), while siCD47 inhibits CD47 expression to promote phagocytosis of tumor cells by macrophages, which together enhance the immunocidal effect of GBM.[72]. Here, CD47 is linked to glioblastoma.